| Package | dk.kip.rkkp.fhir.ig.core |
| Type | CodeSystem |
| Id | ATC |
| FHIR Version | R4 |
| Source | https://kip.rkkp.dk/fhir/https://build.fhir.org/ig/KIP-infrastructure/implementation-guide/CodeSystem-ATC.html |
| URL | https://kip.rkkp.dk/fhir/CodeSystem/ATC |
| Version | 2.12.0 |
| Status | active |
| Date | 2022-06-14T00:00:00+02:00 |
| Name | ATC |
| Title | WHO ATC |
| Description | WHO ATC code system. Link: http://www.whocc.no/atc |
| Content | fragment |
| ValueSet | |
| ATCAntibiotikaprofylakseDKR | ATC - Antibiotikaprofylakse (DKR) |
| ATCChemoCLL | ATC_CLL_kemo |
| ATCChemoPreparation | ATC: Præparater for kemobehandling |
| ATCDMPN | ATC DMPN |
| ATCDMPN202410 | ATC DMPN 202410 |
| ATCImmunotherapyCLL | ATC_CLL_immunterapi |
| ATCTargetCLL | ATC_CLL_target |
| ATCTromboseprofylakseDKR | ATC - Tromboseprofylakse (DKR) |
| AntibiotikaprofylakseDHR | Antibiotikaprofylakse (DHR) |
| AntibiotikaprofylakseDKRR | Antibiotikaprofylakse (DKRR) |
| BehandlingCML | Behandling (CML) |
| BehandlingCMMLMDS | Behandlinger foretaget i forbindelse med CMML (MDS) |
| BehandlingMDS | Behandlinger foretaget i forbindelse med MDS (MDS) |
| BehandlingsTypeStamcellestoetteLYFO | Behandlingsttype - Stamcellestøtte (LYFO) |
| BloedningsprofylakseDHR | Blødningsprofylakse (DHR) |
| Immunoterapi | Immunoterapi |
| Kemoterapiregime | Kemoterapiregime |
| Radioimmunoterapi | Radioimmunoterapi |
| TreatmentPreservation | Vedligeholdelsesbehandling |
| TreatmentScheduledDAMYDA | Planlagt behandling (DAMYDA) |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: CodeSystem ATC
This case-sensitive code system https://kip.rkkp.dk/fhir/CodeSystem/ATC provides a fragment that includes following codes in an undefined hierarchy:
FHIR{
"resourceType": "CodeSystem",
"id": "ATC",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "https://kip.rkkp.dk/fhir/CodeSystem/ATC",
"identifier": [
{
"value": "urn:oid:2.16.840.1.113883.6.73"
}
],
"version": "2.12.0",
"name": "ATC",
"title": "WHO ATC",
"status": "active",
"date": "2022-06-14T00:00:00+02:00",
"publisher": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"contact": [
{
"name": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"telecom": [
{
"system": "url",
"value": "https://trifork.com"
},
{
"system": "email",
"value": "rbk@trifork.com"
}
]
}
],
"description": "WHO ATC code system. Link: http://www.whocc.no/atc",
"caseSensitive": true,
"content": "fragment",
"concept": [
{
"code": "B01A",
"display": "ANTITHROMBOTIC AGENTS",
"definition": "B01A - ANTITHROMBOTIC AGENTS",
"concept": [
{
"code": "B01AA03",
"display": "warfarin",
"definition": "B01AA03 - warfarin"
},
{
"code": "B01AB01",
"display": "heparin",
"definition": "B01AB01 - heparin"
},
{
"code": "B01AB04",
"display": "dalteparin",
"definition": "B01AB04 - dalteparin"
},
{
"code": "B01AB05",
"display": "enoxaparin",
"definition": "B01AB05 - enoxaparin"
},
{
"code": "B01AB10",
"display": "tinzaparin",
"definition": "B01AB10 - tinzaparin"
},
{
"code": "B01AC06",
"display": "acetylsalicylic acid",
"definition": "B01AC06 - acetylsalicylic acid"
},
{
"code": "B01AE07",
"display": "dabigatran etexilate",
"definition": "B01AE07 - dabigatran etexilate"
},
{
"code": "B01AF01",
"display": "rivaroxaban",
"definition": "B01AF01 - rivaroxaban"
},
{
"code": "B01AF02",
"display": "apixaban",
"definition": "B01AF02 - apixaban"
},
{
"code": "B01AX05",
"display": "fondaparinux",
"definition": "B01AX05 - fondaparinux"
}
]
},
{
"code": "B02AA02",
"display": "tranexamic acid",
"definition": "B02AA02 - Tranexamic acid"
},
{
"code": "B03XA01",
"display": "erythropoietin",
"definition": "B03XA01 - erythropoietin"
},
{
"code": "C10AA",
"display": "HMG CoA reductase inhibitors",
"definition": "C10AA - HMG CoA reductase inhibitors"
},
{
"code": "H02",
"display": "CORTICOSTEROIDS FOR SYSTEMIC USE",
"definition": "H02 - CORTICOSTEROIDS FOR SYSTEMIC USE"
},
{
"code": "J01CF01",
"display": "dicloxacillin",
"definition": "J01CF01 - dicloxacillin"
},
{
"code": "J01CF02",
"display": "cloxacillin",
"definition": "J01CF02 - cloxacillin"
},
{
"code": "J01CF03",
"display": "meticillin",
"definition": "J01CF03 - meticillin"
},
{
"code": "J01CF05",
"display": "flucloxacillin",
"definition": "J01CF05 - flucloxacillin"
},
{
"code": "J01DB01",
"display": "cefalexin",
"definition": "J01DB01 - cefalexin"
},
{
"code": "J01DB03",
"display": "cefalotin",
"definition": "J01DB03 - cefalotin"
},
{
"code": "J01DC02",
"display": "cefuroxime",
"definition": "J01DC02 - cefuroxime"
},
{
"code": "J01FA01",
"display": "erythromycin",
"definition": "J01FA01 - erythromycin"
},
{
"code": "J01GB03",
"display": "gentamicin",
"definition": "J01GB03 - gentamicin"
},
{
"code": "J01XA01",
"display": "vancomycin",
"definition": "J01XA01 - vancomycin"
},
{
"code": "L01AA01",
"display": "cyclophosphamide",
"definition": "L01AA01 - cyclophosphamide"
},
{
"code": "L01AA02",
"display": "chlorambucil",
"definition": "L01AA02 - chlorambucil"
},
{
"code": "L01AA03",
"display": "melphalan",
"definition": "L01AA03 - melphalan"
},
{
"code": "L01AA06",
"display": "ifosfamide",
"definition": "L01AA06 - ifosfamide"
},
{
"code": "L01AA09",
"display": "bendamustine",
"definition": "L01AA09 - bendamustine"
},
{
"code": "L01AB01",
"display": "busulfan",
"definition": "L01AB01 - busulfan"
},
{
"code": "L01AC01",
"display": "thiotepa",
"definition": "L01AC01 thiotepa"
},
{
"code": "L01AD01",
"display": "carmustine",
"definition": "L01AD01 - carmustine"
},
{
"code": "L01AX03",
"display": "temozolomide",
"definition": "L01AX03 - temozolomide"
},
{
"code": "L01AX04",
"display": "dacarbazine",
"definition": "L01AX04 - dacarbazine"
},
{
"code": "L01BB05",
"display": "fludarabine",
"definition": "L01BB05 - fludarabine"
},
{
"code": "L01BC02",
"display": "fluorouracil",
"definition": "L01BC02 - Fluorouracil (5-FU)"
},
{
"code": "L01BC05",
"display": "gemcitabine",
"definition": "L01BC02 - Gemcitabine"
},
{
"code": "L01BC06",
"display": "capecitabine",
"definition": "L01BC06 - Capecitabine"
},
{
"code": "L01BC07",
"display": "azacitidine",
"definition": "L01BC07 - azacitidine"
},
{
"code": "L01CA02",
"display": "vincristine",
"definition": "L01CA02 - vincristine"
},
{
"code": "L01CA04",
"display": "vinorelbine",
"definition": "L01CA04 - Vinorelbine"
},
{
"code": "L01CB01",
"display": "etoposide",
"definition": "L01CB01 - etoposide"
},
{
"code": "L01CD01",
"display": "paclitaxel",
"definition": "L01CD01 - Paclitaxel"
},
{
"code": "L01CD02",
"display": "docetaxel",
"definition": "L01CD02 - Docetaxel"
},
{
"code": "L01CE02",
"display": "irinotecan",
"definition": "L01CE02 - Irinotecan"
},
{
"code": "L01DB01",
"display": "doxorubicin",
"definition": "L01DB01 - Doxorubicin"
},
{
"code": "L01DB03",
"display": "epirubicin",
"definition": "L01DB03 - Epirubicin"
},
{
"code": "L01DB07",
"display": "mitoxantrone",
"definition": "L01DB07 - mitoxantrone"
},
{
"code": "L01DB11",
"display": "pixantrone",
"definition": "L01DB11 - pixantrone"
},
{
"code": "L01DC01",
"display": "bleomycin",
"definition": "L01DC01 - bleomycin"
},
{
"code": "L01EA",
"display": "BCR-ABL tyrosine kinase inhibitors",
"concept": [
{
"code": "L01EA01",
"display": "imatinib",
"definition": "L01EA01 - imatinib"
},
{
"code": "L01EA02",
"display": "dasatinib",
"definition": "L01EA02 - dasatinib"
},
{
"code": "L01EA03",
"display": "nilotinib",
"definition": "L01EA03 - nilotinib"
},
{
"code": "L01EA04",
"display": "bosutinib",
"definition": "L01EA04 - bosutinib"
},
{
"code": "L01EA05",
"display": "ponatinib",
"definition": "L01EA05 - ponatinib"
},
{
"code": "L01EA06",
"display": "Asciminib",
"definition": "L01EA06 - Asciminib"
}
]
},
{
"code": "L01EB",
"display": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
"definition": "L01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors"
},
{
"code": "L01EH",
"display": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors",
"definition": "L01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors"
},
{
"code": "L01EJ",
"display": "Janus-associated kinase (JAK) inhibitors",
"definition": "Janus associerede kinase (JAK) hæmmere",
"concept": [
{
"code": "L01EJ01",
"display": "ruxolitinib",
"definition": "L01EJ01 - ruxolitinib"
}
]
},
{
"code": "L01EK",
"display": "Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors",
"definition": "L01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors"
},
{
"code": "L01EL01",
"display": "ibrutinib",
"definition": "L01EL01 - ibrutinib"
},
{
"code": "L01EL02",
"display": "acalabrutinib",
"definition": "L01EL02 - acalabrutinib"
},
{
"code": "L01EM01",
"display": "idelalisib",
"definition": "L01EM01 - idelalisib"
},
{
"code": "L01EN",
"display": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors",
"definition": "L01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors"
},
{
"code": "L01FA01",
"display": "rituximab",
"definition": "L01FA01 - rituximab"
},
{
"code": "L01FA02",
"display": "ofatumumab",
"definition": "L01FA02 - ofatumumab"
},
{
"code": "L01FA03",
"display": "obinutuzumab",
"definition": "L01FA03 - obinutuzumab"
},
{
"code": "L01FC01",
"display": "daratumumab",
"definition": "L01FC01 - daratumumab"
},
{
"code": "L01FC02",
"display": "isatuximab",
"definition": "L01FC02 - isatuximab"
},
{
"code": "L01FD01",
"display": "trastuzumab",
"definition": "L01FD01 - Trastuzumab"
},
{
"code": "L01FF",
"display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
"definition": "L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
"concept": [
{
"code": "L01FF01",
"display": "nivolumab",
"definition": "L01FF01 - Nivolumab"
},
{
"code": "L01FF02",
"display": "pembrolizumab",
"definition": "L01FF02 - Pembrolizumab"
}
]
},
{
"code": "L01FG01",
"display": "bevacizumab",
"definition": "L01FG01 - Bevacizumab"
},
{
"code": "L01FX05",
"display": "brentuximab vedotin",
"definition": "L01FX05 - brentuximab vedotin"
},
{
"code": "L01FX08",
"display": "elotuzumab",
"definition": "L01FX08 - elotuzumab"
},
{
"code": "L01FX14",
"display": "polatuzumab vedotin",
"definition": "L01FX14 - polatuzumab vedotin"
},
{
"code": "L01XA01",
"display": "cisplatin",
"definition": "L01XA01 - Cisplatin"
},
{
"code": "L01XA02",
"display": "carboplatin",
"definition": "L01XA02 - Carboplatin"
},
{
"code": "L01XA03",
"display": "oxaliplatin",
"definition": "L01XA03 - Oxaliplatin"
},
{
"code": "L01XG01",
"display": "bortezomib",
"definition": "L01XG01 - bortezomib"
},
{
"code": "L01XG02",
"display": "carfilzomib",
"definition": "L01XG02 - carfilzomib"
},
{
"code": "L01XG03",
"display": "ixazomib",
"definition": "L01XG03 - ixazomib"
},
{
"code": "L01XH",
"display": "Histone deacetylase (HDAC) inhibitors",
"definition": "L01XH - Histone deacetylase (HDAC) inhibitors",
"concept": [
{
"code": "L01XH01",
"display": "vorinostat",
"definition": "L01XH01 - vorinostat"
},
{
"code": "L01XH03",
"display": "panobinostat",
"definition": "L01XH03 - panobinostat"
}
]
},
{
"code": "L01XX05",
"display": "hydroxycarbamide",
"definition": "L01XX05 - hydroxycarbamide"
},
{
"code": "L01XX35",
"display": "anagrelide",
"definition": "L01XX35 - anagrelide"
},
{
"code": "L01XX52",
"display": "venetoclax",
"definition": "L01XX52 - venetoclax"
},
{
"code": "L03AB",
"display": "Interferons",
"definition": "L03AB - Interferons"
},
{
"code": "L04A",
"display": "IMMUNOSUPPRESSANTS",
"definition": "L04A - IMMUNOSUPPRESSANTS",
"concept": [
{
"code": "L04AA",
"display": "Selective immunosuppressants",
"definition": "L04AA - Selective immunosuppressants",
"concept": [
{
"code": "L04AA34",
"display": "alemtuzumab",
"definition": "L04AA34 - alemtuzumab"
},
{
"code": "L04AA40",
"display": "cladribine",
"definition": "L04AA40 - cladribine"
}
]
}
]
},
{
"code": "L04AD01",
"display": "ciclosporin",
"definition": "L04AD01 - ciclosporin"
},
{
"code": "L04AX02",
"display": "thalidomide",
"definition": "L04AX02 - thalidomide"
},
{
"code": "L04AX04",
"display": "lenalidomide",
"definition": "L04AX04 - lenalidomide"
},
{
"code": "L04AX06",
"display": "pomalidomide",
"definition": "L04AX06 - pomalidomide"
},
{
"code": "M05BA03",
"display": "pamidronic acid",
"definition": "M05BA03 - pamidronic acid"
},
{
"code": "M05BA08",
"display": "zoledronic acid",
"definition": "M05BA08 - zoledronic acid"
},
{
"code": "M05BX04",
"display": "denosumab",
"definition": "M05BX04 - denosumab"
},
{
"code": "S01LA08",
"display": "bevacizumab",
"definition": "S01LA08 - Bevacizumab"
},
{
"code": "V10X",
"display": "OTHER THERAPEUTIC RADIOPHARMACEUTICALS",
"definition": "V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS",
"concept": [
{
"code": "V10XA53",
"display": "tositumomab/iodine (131I) tositumomab",
"definition": "V10XA53 - tositumomab/iodine (131I) tositumomab"
},
{
"code": "V10XX02",
"display": "ibritumomab tiuxetan (90Y)",
"definition": "V10XX02 - ibritumomab tiuxetan (90Y)"
}
]
}
]
}